Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

News | Artificial Heart

FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study

February 10, 2021 - The U.S. Food and Drug Administration (FDA) has granted artificial heart developer Carmat approval ...

February 10, 2021

The FineHeart Transcutaneous Energy Transfer (TET) System for the ICOMS cardiac assist device. 1. The ICOMS heart pump. 2. The implanted TET transfer pad. 3. The external energy transfer pad.

News | Heart Failure

Wireless Transcutaneous Energy Transfer (TET) System for Powering a LVAD is Successful

January 13, 2021 — FineHeart, a preclinical-stage medical device company developing a novel left ventricular assist ...

January 13, 2021

A coronary artery bypass graft (CABG) procedure where blockages in the coronaries are bypassed using a blood vessel harvested from elsewhere in the body and connected to the vessel past the blockage to supply blood to the heart. A new study shows better outcomes seen in multiple vs. single coronary artery bypass grafts (CABG) in men and sex appears to play a role in mortality. Getty Images

News | Womens Cardiovascular Health

Long-term Outcomes After Coronary Bypass Show Worse Outcomes for Women

January 6, 2020 — A new Weill Cornell Medicine found the risk of dying seven years after coronary artery bypass graft ...

January 06, 2021

Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) so the company to initiate a U.S. clinical study of its Tria biopolymer mitral surgical heart valve.

News | Heart Valve Technology

Foldax to Initiate FDA Clinical Study of Biopolymer Mitral Heart Valve

December 14, 2020 - Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an ...

December 14, 2020

CMS coverage changes effective as of Dec. 2, 2020 will open up the use of LVADs to more Medicare patients, including use of the HeartWare and HeartMate ventricular assist devices.

News | Heart Failure

CMS Updates Coverage Policies for Artificial Hearts and Ventricular Assist Devices

December 2, 2020 — The Centers for Medicare and Medicaid Services (CMS) finalized updates to Medicare coverage policies ...

December 02, 2020

RIVER trial is the largest study assessing the efficacy and safety of the anticoagulant rivaroxaban in patients with an artificial mitral valve to correct an irregular heart rhythm

News

Rivaroxaban is Comparable to Warfarin for Bioprosthetic Mitral Valves and AF

November 18, 2020 — The primary results from the RIVER Trial, Rivaroxaban for Valvular Heart disease and Atrial ...

November 18, 2020

The Medtronic SEEQ mobile cardiac telemetry system, pictured here, and the Icentia CardioSTAT cardiac rhythm monitoring device both found in reased rates of post-operative atrial fibrillation in the SEARCH-AF trial presented at the American Heart Association annual meeting. #AHA #AHA20 #AHA2020

News | Atrial Fibrillation

Patients at Risk of AF May Need Extra Monitoring After Heart Surgery

November 16, 2020 — Atrial fibrillation (AF), an irregular heartbeat that can increase the likelihood of stroke, was ...

November 16, 2020

The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario, Canada, represents a new frontier in cardiac surgery. The customized OR features a Siemens Artis Pheno angiogray system with 3-D imaging capability with an integrated OR table that together improve workflow, increase efficiency and ensure a high-level of infection control.

News | Hybrid OR

Intelligent Hybrid Operating Room Help Redefine Cardiac Care at London Health Sciences Centre

October 2, 2020 — The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario ...

October 02, 2020

The Medtronic Heartware and Abbott Heartmate 3 LVADs and others currently cleared by the FDA might be easier to use in Medicare advanced heart failure patients under new guidelines proposed by CMS. Photo by Dave Fornell

Feature | Heart Failure | Dave Fornell, Editor

CMS Proposes Coverage Updates for Artificial Hearts and Ventricular Assist Devices

August 21, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) proposed updates to coverage policies for to ...

August 21, 2020

The Smidt Heart Institute at Cedars-Sinai is working with the Keck Medicine of USC heart surgery team to expand care for children and adults with congenital heart disease. An echocardiographer helps with cardiac ultrasound imaging in a hybrid OR during a congenital case using a Siemens SC2000 imaging system. Photo by Cedars-Sinai.

News | Congenital Heart

Smidt Heart Institute Enhances Congenital Heart Program to Follow Patients as Neonates Through Adulthood

August 10, 2020 - The Guerin Family Congenital Heart Program in the Smidt Heart Institute at Cedars-Sinai is expanding ...

August 10, 2020

The Edwards Konect Resilia aortic valved conduit (AVC).

News | Heart Valve Technology

FDA Clears Edwards Konect Resilia Aortic Valved Conduit For Complex Aortic Valve Surgeries

July 15, 2020 — The U.S. Food and Drug Administration (FDA) granted clearance for the Edwards Lifesciences Corp. Konect ...

July 15, 2020

The Foldax Tria surgical valve reimagines the heart valve by incorporating a new, proprietary biopolymer, what the vendor calls LifePolymer, with an innovative valve design intended to eliminate calcification, withstand stresses and strains without failure, and restore patient quality of life without lifelong use of anticoagulants. Tria is also the first heart valve to be robotically manufactured, reducing variability, enabling high precision, repeatability and better quality control.

News | Heart Valve Technology

Foldax Gets $20 Million to Finance Innovative Heart Valve Technology

June 23, 2020 – Heart valve start-up Foldax is looking to reinventing several aspects of the prosthetic heart valve ...

June 23, 2020

A Philips Healthcare transesophageal echocardiography (TEE) system in use in a hybrid OR.

News | Cardiovascular Ultrasound

New Guideline Outlines Use of Transesophageal Echo to Assist Surgical Decision-making

June 4, 2020 — Intra-operative transesophageal echocardiography (TEE) is a versatile diagnostic and monitoring tool used ...

June 04, 2020

Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2

Feature | Cardiovascular Business

Societies Issue Guide to Safely Resume Cardiovascular Procedures and Tests

The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework ...

June 03, 2020

News | Artificial Heart

First Implantation of Carmat Total Artificial Heart in Denmark

May 27, 2020 — Carmat, a developer of the of a next generation advanced total artificial heart, announces the first ...

May 27, 2020